Nissay Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,217
| Closed | -$1.16M | – | 734 |
|
|
2024
Q4 | $1.16M | Buy |
6,217
+58
| +0.9% | +$10.8K | 0.01% | 625 |
|
|
2024
Q3 | $1.21M | Buy |
6,159
+190
| +3% | +$37.4K | 0.01% | 625 |
|
|
2024
Q2 | $1.23M | Buy |
5,969
+128
| +2% | +$26.4K | 0.01% | 599 |
|
|
2024
Q1 | $1.58M | Buy |
5,841
+92
| +2% | +$24.9K | 0.01% | 561 |
|
|
2023
Q4 | $1.36M | Buy |
5,749
+223
| +4% | +$52.7K | 0.01% | 564 |
|
|
2023
Q3 | $1.08M | Buy |
5,526
+186
| +3% | +$36.5K | 0.01% | 593 |
|
|
2023
Q2 | $1.12M | Sell |
5,340
-36
| -0.7% | -$7.57K | 0.01% | 585 |
|
|
2023
Q1 | $1.08M | Sell |
5,376
-181
| -3% | -$36.5K | 0.01% | 583 |
|
|
2022
Q4 | $1.21M | Sell |
5,557
-111
| -2% | -$24.2K | 0.01% | 553 |
|
|
2022
Q3 | $1.12M | Buy |
5,668
+239
| +4% | +$47K | 0.01% | 561 |
|
|
2022
Q2 | $1.16M | Sell |
5,429
-168
| -3% | -$36K | 0.01% | 553 |
|
|
2022
Q1 | $1.59M | Buy |
5,597
+136
| +2% | +$38.6K | 0.01% | 522 |
|
|
2021
Q4 | $2.06M | Buy |
5,461
+107
| +2% | +$40.3K | 0.02% | 469 |
|
|
2021
Q3 | $2.21M | Buy |
5,354
+188
| +4% | +$77.6K | 0.02% | 433 |
|
|
2021
Q2 | $1.91M | Buy |
+5,166
| New | +$1.91M | 0.02% | 458 |
|